Photo text: Olof Sandén, Vice President, Bactiguard
Bactiguard has signed an exclusivity agreement with Capa Medikal, one of the strongest established medical suppliers in Turkey. Capa Medikal will sell Bactiguard´s complete infection protection portfolio, including urinary, intravenous and respiratory catheters.
Mr. Zeki Avsar, General Manager, Capa Medikal: “Partnering with Bactiguard AB will allow Capa Medikal to enlarge its services to the Turkish Health Care system by providing a highly competitive range of products. Bactiguard’s products not only prevent infections, but also reduces the use of antibiotics and saves health care expenditures”.
“Bactiguard´s unique coating that prevents bacteria from adhesion and forming of biofilms has a large role to fill in these markets” says Olof Sandén, Vice President of Bactiguard. “I am proud that we together with Capa Medikal can improve patient safety in Turkey with our infection protection portfolio and contribute to improved health care in Turkey”.
Capa Medikal represents many well-known companies such as B Braun, Mölnlycke Health Care, Sempermed and others.
Health care associated infections (HAI) are the fourth largest cause of death in the world. The Bactiguard® coating has been applied to urinary catheters in the U.S. since 1995 and over 125 million Bactiguard coated catheters have been used in clinical practice all over the world. The Bactiguard technology consists of an extremely thin noble metal coating that reduces bacterial adhesion and is biocompatible.
Bactiguard provides world-leading solutions preventing health care associated infections - the 4th largest cause of death in the western world. By using Bactiguard technology Governments can reduce healthcare cost, lower the use of antibiotics and save lives. The Bactiguard technology consists of an extremely thin noble metal coating that reduces bacterial adhesion and is biocompatible. It can be used on all sorts of medical devices. The Bactiguard® coated urinary catheter has since 1995 been used by more than 125 million patients in the US. Today Bactiguard offers a full range portfolio within infection prevention in the urinary tract, respiratory tract and blood stream.